Susquehanna International Group
BDTX icon

Susquehanna International Group’s Black Diamond Therapeutics BDTX Stock Holding History

Susquehanna International Group’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.3K Sell
11,400
-18,400
-62% -$43.8K ﹤0.01% 12816
2025
Q4 		$72.4K Buy
+29,800
New +$106K ﹤0.01% 11612
2025
Q2 		– Sell
-20,000
Closed -$31K – 12656
2025
Q1 		$31K Sell
20,000
-6,900
-26% -$14.5K ﹤0.01% 11999
2024
Q4 		$57.6K Sell
26,900
-43,600
-62% -$125K ﹤0.01% 11620
2024
Q3 		$307K Buy
70,500
+52,800
+298% +$287K ﹤0.01% 9553
2024
Q2 		$82.5K Buy
+17,700
New +$95K ﹤0.01% 11150
2023
Q4 		– Sell
-26,200
Closed -$75.2K – 12340
2023
Q3 		$75.2K Sell
26,200
-17,700
-40% -$65.2K ﹤0.01% 11104
2023
Q2 		$222K Buy
+43,900
New +$89.7K ﹤0.01% 10064
2022
Q4 		– Sell
-82,300
Closed -$139K – 12406
2022
Q3 		$139K Sell
82,300
-7,600
-8% -$23.4K ﹤0.01% 11341
2022
Q2 		$221K Buy
89,900
+46,700
+108% +$109K ﹤0.01% 10380
2022
Q1 		$120K Buy
43,200
+14,200
+49% +$51.8K ﹤0.01% 11766
2021
Q4 		$155K Sell
29,000
-10,700
-27% -$74.8K ﹤0.01% 11752
2021
Q3 		$336K Buy
39,700
+2,900
+8% +$28.6K ﹤0.01% 10328
2021
Q2 		$449K Sell
36,800
-1,600
-4% -$31.6K ﹤0.01% 9841
2021
Q1 		$932K Buy
+38,400
New +$1.04M ﹤0.01% 7926

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group's BDTX Position: Q1 2026 in Review

Susquehanna International Group reduced its Black Diamond Therapeutics (BDTX) stake by 25% in Q1 2026, selling an estimated $61.5K and leaving 78,858 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #11877.

Susquehanna International Group first reported a position in BDTX in Q4 2020 and has held it in 20 quarters since. The position peaked at $2.15M in Q1 2024. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • Susquehanna International Group held 78,858 shares of Black Diamond Therapeutics worth $168K as of Q1 2026.
  • Susquehanna International Group sold 25,866 Black Diamond Therapeutics shares in Q1 2026, an estimated $61.5K.
  • Black Diamond Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11877 holding.
  • Susquehanna International Group first reported a position in Black Diamond Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Susquehanna International Group's Black Diamond Therapeutics position peaked at $2.15M in Q1 2024.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.